This come out of a life science report dated 25/7
..Australian regenative medicine firm lands a great partner in China ........China addresses a significant opportunity for instance 17% of the 1.3+ billion people there have cardiovascular disease,around 500,000 individuals PER YEAR experience cardiac arrest due to air quality quaility, great incidents of smoking , and excessive salt intake ..It's estimated that cardiovascular disease drug market in China is around $45 Billion dollars in 2018 ...Cheers PS of course that's only an extract of the report ..
MSB trading, page-1066
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23545 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 339479 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |